insights_auto
Outlook: 73.7% bullish·10.5% bearish
Go to analysischevron_right
PCRX:NASDAQ
Pacira Biosciences Inc
$36.31
arrow_downward
-0.22%(-0.080) 1D
$36.31
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 9 analysts giving stock ratings to PCRX in the past 3 months
Hold
Buy
0
Hold
8
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for PCRX in the last 3 months.
Highest
Current $36.31
$36.50 (+0.52%)
Average
$32.86 (-9.50%)
Lowest
$23.00 (-36.66%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Daniel Clark Leerink Partners | Hold | Reiterated | $36.50 | +0.5% | 10/09/2026 |
Douglas Miehm RBC Capital | Hold | Reiterated | $36.50 | +0.5% | 10/08/2026 |
Douglas Tsao H.C. Wainwright | Hold | Downgraded | $36.50 | +0.5% | 10/09/2026 |
Les Sulewski Oppenheimer | Hold | Downgraded | - | - | 10/08/2026 |
Dennis Ding Jefferies | Hold | Downgraded | $36.00 | -0.9% | 10/08/2026 |
Serge Belanger Needham | Hold | Downgraded | - | - | 10/08/2026 |
Anish Nikhanj Truist Financial | Hold | Downgraded | $36.50 | +0.5% | 10/09/2026 |
Unknown Analyst Oppenheimer | Buy | Initiated | $32.00 | -11.9% | 09/23/2026 |
Gregory Renza Truist Financial | Buy | Initiated | $30.00 | -17.4% | 08/17/2026 |
Jenna Davidner Barclays | Hold | Maintained | $25.00 | -31.1% | 08/17/2026 |
Hardik Parikh J.P. Morgan | Sell | Maintained | $23.00 | -36.7% | 08/10/2026 |